- Acquisition: Ardian invests in the provider of industrial fastening and locking solutions JPB Système.
- Exit: Ipsen acquires the biotechnology laboratory ImCheck Therapeutics.
- Acquisition: The AI-powered running coaching application Kotcha raises €3.5 million.
- Exit: Altor sells all of its shares in the outdoor clothing manufacturer RevolutionRace.
Ardian
Acquisition: Ardian invests in the provider of industrial fastening and locking solutions JPB Système
Ardian announces its investment in JPB Système (€30 million of revenue in 2022, Île-de-France / FRA), a company that designs and manufactures self-locking solutions to prevent loosening due to vibrations or temperature variations, serving sectors such as aerospace, transportation, defense, energy, and amusement parks, with products ranging from borescope plugs to locking systems for gas and fluid connections, as well as intelligent bolt tension monitoring solutions, while internally integrating design and production processes based on Industry 4.0 technologies, such as automation and IoT, to ensure efficiency and reliability. This acquisition will strengthen JPB Système’s leading position in the aerospace market, accelerate its international development, support its technological innovations, and optimize its growth through Ardian’s expertise and network (Ardian, press release)
Gimv
Exit: Ipsen acquires the biotechnology laboratory ImCheck Therapeutics
Ipsen (Île-de-France / FRA), a laboratory specializing in the development, production, and commercialization of drugs in the fields of oncology, neurology, and rare diseases, acquires ImCheck Therapeutics (Provence-Alpes-Côte d’Azur / FRA), a biotechnology company specializing in cancer immunotherapy and autoimmune diseases. As part of this operation, ImCheck’s historical investors, including Gimv, Leukemia & Lymphoma Society (LLS), Kurma Partners, Bpifrance Investissement, Pfizer Venture Investment, Andera Partners, BB Biotech, Alexandria Venture, Agent Capital, Wellington Partners, EQT Partners, Eurazeo, Earlybird Venture Capital, and an ImCheck executive, are selling all of their shares. This acquisition will allow Ipsen to strengthen its leadership in oncology and enhance its portfolio through the integration of ICT01, ImCheck Therapeutics’ flagship clinical program for the treatment of acute myeloid leukemia (Gimv, press release)
TRUE CAPITAL
Acquisition: The AI-powered running coaching application Kotcha raises €3.5 million
Kotcha (Île-de-France / FRA), an AI-powered running coaching application inspired by Eliud Kipchoge’s training methods, which offers adaptive weekly planning, real-time feedback, and personalized advice, and synchronizes running devices to adjust programs based on the user’s progress and daily conditions, raises €3.5 million in a pre-seed funding round led by Racine² (a fund managed by Serena and makesense), with participation from True Capital, Motier Ventures, and other investors from the consumer, health, running, and sports sectors. This funding will allow Kotcha to accelerate the launch of its application in European and international markets, in order to realize its vision of improving individuals’ physical, mental, and social well-being through running (True Capital, press release)
ALTOR EQUITY PARTNERS
Exit: Altor sells all of its shares in the outdoor clothing manufacturer RevolutionRace
Altor Equity Partners announces the sale of all its shares in RevolutionRace (SEK 1,925 million of revenue in 2025, Gotland / SWE), a company that manufactures and sells outdoor and leisure clothing. The public offer concerns the sale of 16,299,438 shares of the company at a price of 60 SEK per share, representing approximately 978 million SEK in total. Altor has supported RevolutionRace since 2017 and has helped it multiply its revenue by more than ten, thanks to international expansion, diversification of its product range, and the opening of new distribution channels (Altor Equity Partners, press release)
